As of 2026-04-06, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (14.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -442763.0%.
The range of the Relative Valuation is (10.58) - (17.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 18.9x | 15.0x |
| Forward P/E multiples | 10.0x - 18.0x | 13.6x |
| Fair Price | (10.58) - (17.93) | (14.17) |
| Upside | -330621.7% - -560495.8% | -442763.0% |
| Date | P/E |
| 2026-03-24 | -0.00 |
| 2026-03-23 | -0.00 |
| 2026-03-20 | -0.00 |
| 2026-03-19 | -0.00 |
| 2026-03-18 | -0.00 |
| 2026-03-17 | -0.00 |
| 2026-03-16 | -0.00 |
| 2026-03-13 | -0.00 |
| 2026-03-12 | -0.00 |
| 2026-03-11 | -0.00 |
| 2026-03-10 | -0.00 |
| 2026-03-09 | -0.00 |
| 2026-03-06 | -0.00 |
| 2026-03-05 | -0.00 |
| 2026-03-04 | -0.00 |
| 2026-03-03 | -0.00 |
| 2026-03-02 | -0.00 |
| 2026-02-27 | -0.00 |
| 2026-02-26 | -0.00 |
| 2026-02-25 | -0.00 |
| 2026-02-24 | -0.00 |
| 2026-02-23 | -0.00 |
| 2026-02-20 | -0.00 |
| 2026-02-19 | -0.00 |
| 2026-02-18 | -0.00 |
| 2026-02-17 | -0.00 |
| 2026-02-13 | -0.00 |
| 2026-02-12 | -0.00 |
| 2026-02-11 | -0.00 |
| 2026-02-10 | -0.00 |
| 2026-02-09 | -0.00 |
| 2026-02-06 | -0.00 |
| 2026-02-05 | -0.00 |
| 2026-02-04 | -0.00 |
| 2026-02-03 | -0.00 |
| 2026-02-02 | -0.00 |
| 2026-01-30 | -0.00 |
| 2026-01-29 | -0.00 |
| 2026-01-28 | -0.00 |
| 2026-01-27 | -0.00 |
| 2026-01-26 | -0.00 |
| 2026-01-23 | -0.00 |
| 2026-01-22 | -0.00 |
| 2026-01-21 | -0.00 |
| 2026-01-20 | -0.00 |
| 2026-01-16 | -0.00 |
| 2026-01-15 | -0.00 |
| 2026-01-14 | -0.00 |
| 2026-01-13 | -0.00 |
| 2026-01-12 | -0.00 |